Jungmee Kang
University of Akron
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jungmee Kang.
Asaio Journal | 2009
Sharon Grundfest-Broniatowski; Gurkan Tellioglu; Ken S. Rosenthal; Jungmee Kang; Gabor Erdodi; Baris Yalcin; Miko Cakmak; Judith Drazba; Ana E. Bennett; Lina Lu; Joseph P. Kennedy
We have developed a replaceable bioartificial pancreas to treat diabetes utilizing a unique cocontinous amphiphilic conetwork membrane created for macroencapsulation and immunoisolation of porcine islet cells (PICs). The membrane is assembled from hydrophilic poly(N,N-dimethyl acrylamide) and hydrophobic/oxyphilic polydimethylsiloxane chains cross-linked with hydrophobic/oxyphilic polymethylhydrosiloxane chains. Our hypothesis is that this membrane allows the survival of xenotransplanted PICs in the absence of prevascularization or immunosuppression because of its extraordinarily high-oxygen permeability and small hydrophilic channel dimensions (3–4 nm). The key components are a 5–10 μm thick semipermeable amphiphilic conetwork membrane reinforced with an electrospun nanomat of polydimethylsiloxane-containing polyurethane, and a laser-perforated nitinol scaffold to provide geometric stability. Devices were loaded with PICs and tested for their ability to maintain islet viability without prevascularization, prevent rejection, and reverse hyperglycemia in three pancreatectomized dogs without immunosuppression. Tissue tolerance was good and there was no systemic toxicity. The bioartificial pancreas protected PICs from toxic environments in vitro and in vivo. Islets remained viable for up to 3 weeks without signs of rejection. Neovascularization was observed. Hyperglycemia was not reversed, most likely because of insufficient islet mass. Further studies to determine long-term islet viability and correction of hyperglycemia are warranted.
Macromolecular Bioscience | 2010
Jungmee Kang; Gabor Erdodi; Joseph P. Kennedy; Hongshiue Chou; Lina Lu; Sharon Grundfest-Broniatowski
Research continued toward a bioartificial pancreas (BAP). Our BAPs consist of a perforated nitinol scaffold coated with reinforced amphiphilic conetwork membranes and contain live pancreatic islets. The membranes are assemblages of cocontinuous hydrophobic domains and hydrophilic channels whose diameters were varied by the MW of hydrophilic segments between crosslinks (M(c,HI) = 32, 44, and 74 kg x mol(-1)). We studied the diffusion rate of insulin, BSA, and IgG across the membrane of the BAP in the absence of islets. Membranes of M(c,HI) = 74 kg x mol(-1) showed rapid insulin and BSA transport and negligible IgG diffusion. BAPs containing approximately 300 mouse islets showed appropriate response upon glucose challenge in vitro. The BAP implanted into diabetic mice reduced hyperglycemia and maintained islet viability for at least 4 d.
Journal of Polymer Science Part A | 2009
Suresh K. Jewrajka; Jungmee Kang; Gabor Erdodi; Joseph P. Kennedy; Emel Yilgor; Iskender Yilgor
Journal of Polymer Science Part A | 2009
Gabor Erdodi; Jungmee Kang; Joseph P. Kennedy; Emel Yilgor; Iskender Yilgor
Journal of Polymer Science Part A | 2010
Gabor Erdodi; Jungmee Kang; Joseph P. Kennedy
Journal of Polymer Science Part A | 2007
Jungmee Kang; Gabor Erdodi; Joseph P. Kennedy
Journal of Polymer Science Part A | 2011
Jungmee Kang; Gabor Erdodi; Joseph P. Kennedy
Biomedical Microdevices | 2009
Gabor Erdodi; Jungmee Kang; Baris Yalcin; Mukerrem Cakmak; Ken S. Rosenthal; Sharon Grundfest-Broniatowski; Joseph P. Kennedy
Journal of Polymer Science Part A | 2009
Jungmee Kang; Gabor Erdodi; Joseph P. Kennedy; Emel Yilgor; Iskender Yilgor
Journal of Polymer Science Part A | 2010
Jungmee Kang; Gabor Erdodi; Christopher M. Brendel; Daniel Ely; Joseph P. Kennedy